ASX:ATX

Amplia Therapeutics Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume77,249 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Amplia Therapeutics (ASX:ATX) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying ATX stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Amplia Therapeutics, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Amplia Therapeutics vs. (CHV) Stock

Amplia Therapeutics (ASX:ATX) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

Profitability

This table compares Amplia Therapeutics and (CHV)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Amplia Therapeutics	N/A	N/A	N/A
(CHV)	N/A	N/A	N/A

Earnings & Valuation

This table compares Amplia Therapeutics and (CHV)'s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amplia Therapeutics	$894,155.00	0.00	$-3,023,244.00	A($0.03)	N/A
(CHV)	N/A	N/A	N/A	N/A	N/A

(CHV) has lower revenue, but higher earnings than Amplia Therapeutics.

Analyst Recommendations

This is a breakdown of recent ratings for Amplia Therapeutics and (CHV), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amplia Therapeutics	0	0	0	0	N/A
(CHV)	0	0	0	0	N/A

Summary

Amplia Therapeutics beats (CHV) on 1 of the 1 factors compared between the two stocks.

Amplia Therapeutics vs. (DDXS) Stock

Amplia Therapeutics (ASX:ATX) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

Analyst Recommendations

This is a breakdown of recent ratings for Amplia Therapeutics and (DDXS), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amplia Therapeutics	0	0	0	0	N/A
(DDXS)	0	0	0	0	N/A

Earnings & Valuation

This table compares Amplia Therapeutics and (DDXS)'s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amplia Therapeutics	$894,155.00	0.00	$-3,023,244.00	A($0.03)	N/A
(DDXS)	N/A	N/A	N/A	N/A	N/A

(DDXS) has lower revenue, but higher earnings than Amplia Therapeutics.

Profitability

This table compares Amplia Therapeutics and (DDXS)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Amplia Therapeutics	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A

Summary

Amplia Therapeutics beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Amplia Therapeutics vs. (PREV) Stock

(PREV) (CNSX:PREV) and Amplia Therapeutics (ASX:ATX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, profitability, valuation and earnings.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for (PREV) and Amplia Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(PREV)	0	0	0	0	N/A
Amplia Therapeutics	0	0	0	0	N/A

Earnings and Valuation

This table compares (PREV) and Amplia Therapeutics' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(PREV)	N/A	N/A	N/A	N/A	N/A
Amplia Therapeutics	$894,155.00	0.00	$-3,023,244.00	A($0.03)	N/A

(PREV) has higher earnings, but lower revenue than Amplia Therapeutics.

Profitability

This table compares (PREV) and Amplia Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(PREV)	N/A	N/A	N/A
Amplia Therapeutics	N/A	N/A	N/A

Summary

Amplia Therapeutics beats (PREV) on 1 of the 1 factors compared between the two stocks.

Amplia Therapeutics vs. (TNGN) Stock

(TNGN) (OTCMKTS:TNGN) and Amplia Therapeutics (ASX:ATX) are both health technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, profitability, valuation and earnings.

Earnings and Valuation

This table compares (TNGN) and Amplia Therapeutics' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(TNGN)	N/A	N/A	N/A	N/A	N/A
Amplia Therapeutics	$894,155.00	0.00	$-3,023,244.00	A($0.03)	N/A

(TNGN) has higher earnings, but lower revenue than Amplia Therapeutics.

Profitability

This table compares (TNGN) and Amplia Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(TNGN)	N/A	N/A	N/A
Amplia Therapeutics	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for (TNGN) and Amplia Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(TNGN)	0	0	0	0	N/A
Amplia Therapeutics	0	0	0	0	N/A

Summary

Amplia Therapeutics beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Amplia Therapeutics vs. 138267 (COM.TO) Stock

138267 (COM.TO) (TSE:COM) and Amplia Therapeutics (ASX:ATX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership and valuation.

Earnings & Valuation

This table compares 138267 (COM.TO) and Amplia Therapeutics' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A
Amplia Therapeutics	$894,155.00	0.00	$-3,023,244.00	A($0.03)	N/A

138267 (COM.TO) has higher earnings, but lower revenue than Amplia Therapeutics.

Profitability

This table compares 138267 (COM.TO) and Amplia Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
138267 (COM.TO)	N/A	N/A	N/A
Amplia Therapeutics	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and price targets for 138267 (COM.TO) and Amplia Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
138267 (COM.TO)	0	0	0	0	N/A
Amplia Therapeutics	0	0	0	0	N/A

Summary

Amplia Therapeutics beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Amplia Therapeutics vs. 17031 Stock

17031 (CNSX:MYM) and Amplia Therapeutics (ASX:ATX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership and valuation.

Earnings & Valuation

This table compares 17031 and Amplia Therapeutics' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
17031	N/A	N/A	N/A	N/A	N/A
Amplia Therapeutics	$894,155.00	0.00	$-3,023,244.00	A($0.03)	N/A

17031 has higher earnings, but lower revenue than Amplia Therapeutics.

Profitability

This table compares 17031 and Amplia Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
17031	N/A	N/A	N/A
Amplia Therapeutics	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and price targets for 17031 and Amplia Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
17031	0	0	0	0	N/A
Amplia Therapeutics	0	0	0	0	N/A

Summary

Amplia Therapeutics beats 17031 on 1 of the 1 factors compared between the two stocks.